Receptors of mammalian trace amines

Drug Addiction: From Basic Research to Therapy

Volumn , Issue , 2008, Pages 327-339

  Lewin, Anita H ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

ADHD; G protein coupled receptor; hypothyroidism associated depression; mammalian; prepulse inhibition; TAAR; Trace amine associated receptor

Indexed keywords

EID: 70349228770     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-76678-2_20     Document Type: Chapter

References (31)

1. Sabelli HC, Mosnaim AD. Phenylethylamine hypothesis of affective behavior. Am J Psychiatry. 1974;131:695-699.
2. Potkin SG, Karoum F, Chuang LW, Cannon-Spoor HE, Phillips I, Wyatt RJ. Phenylethylamine in paranoid chronic schizophrenia. Science. 1979;206:470-471.
3. Davis BA, Boulton AA. The trace amines and their acidic metabolites in depression: An overview. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18:17-45.
4. Sandler M, Ruthven CR, Goodwin BL, Coppen A. Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness. Clin Chim Acta. 1979;93:169-171.
5. Altar C, Wasley A, Martin L. Autoradiographic localization and pharmacology of unique 3Htryptamine binding sites in rat brain. Neuroscience. 1986;17:263-273.
6. Hauger R, Skolnick P, Paul S. Specific 3Hbeta-phenylethylamine binding sites in rat brain. Eur J Pharmacol. 1982;83:147-148.
7. Kellar KJ, Cascio CS. 3HTryptamine: High affinity binding sites in rat brain. Eur J Pharmacol. 1982;78:475-478.
8. Perry DC. 3Htryptamine autoradiography in rat brain and choroid plexus reveals two distinct sites. J Pharmacol Exp Ther. 1986;236:548-559.
9. Ungar F, Mosnaim A, Ungar B, Wolf M. Tyramine-binding by synaptosomes from rat brain: Effect of centrally active drugs. Biol Psychiatry. 1977;12:661-668.
10. Roeder T. Octopamine in invertebrates. Prog Neurobiol. 1999;59:533-561.
11. Borowsky B, Adham N, Jones KA, et al. Trace amines: Identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA. 2001;98:8966-8971.
12. Bunzow JR, Sonders MS, Arttmagangkul S, et al. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a trace amine receptor. Mol Pharmacol. 2001;60:1181-1188.
13. Branchek TA, Blackburn TP. Trace amine receptors as targets for novel therapeutics: Legend, myth and fact. Curr Opin Pharmacol. 2003;3:90-97.
14. Shimazu S, Miklya I. Pharmacological studies with endogenous enhancer substances: 'β-phenethylamine, tryptamine, and their synthetic derivatives. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:421-427.
15. Schmidt N, Ferger B. The biogenic trace amine tyramine induces pronounced hydroxyl radical production via monoamine oxidase dependent mechanism: An in vivo microdialysis study in mouse striatum. Brain Res. 2004;1012:101-107.
16. Davenport AP. Peptide and trace amine orphan receptors: Prospects for new therapeutic targets. Curr Opin Pharmacol. 2003;3:127-134.
17. Berry MD. Mammalian central nervous system trace amines: Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem. 2004;90:257-271.
18. Geracitano R, Federici M, Prisco S, Bernardi G, Mercuri NB. Inhibitory effects of trace amines on rat midbrain dopaminergic neurons. Neuropharmacology. 2004;46:807-814.
19. Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MC. Trace amine associated receptors from structurally and functionally distinct subfamilies of novel G proteincoupled receptors. Genomics. 2005;85:372-385.
20. Miller GM, Madras BK. A trace amine receptor (TAR1) is a novel amphetamine receptor in primate brain poster. Paper presented at: Sixty-fifth Annual Meeting of the College on Problems of Drug Dependence (CPDD), June 15-19, 2003; Bal Harbour, F.L.
21. Yin T, Tu Y, Johnstone EM, Little SP. A Characterization of the Trace Amine 1 Receptor (Program No. 961.5). Paper presented at: 2004 Abstract Viewer/Itinerary Planner, 2004 Online; Washington, DC: Society for Neuroscience.
22. Premont RT, Gainetdinov RR, Caron MG. Following the trace of elusive amines. Proc Natl Acad Sci USA. 2001;98:9474-9475.
23. Duan J, Martinez M, Sanders AR, et al. Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am J Hum Genet. 2004;75:624-638.
24. Madras BK, Verrico C, Jassen A, Miller GM. Attention Deficit Hyperactivity Disorder (ADHD): New Roles for Old Trace Amines and Monoamine Transporters poster. Paper presented at: The American College of Neuropsychopharmacology (ACNP) 43rd Annual Meeting, December 12-16, 2004; San Juan, Puerto Rico.
25. Grandy DK, Scanlan TS. Thyroid Hormone Metabolites and Depression: A New Twist on an Old Tale poster. Paper presented at: The American College of Neuropsychopharmacology (ACNP) 43rd Annual Meeting, December 12-16, 2004; San Juan, Puerto Rico.
26. Scanlan TS, Suchland KL, Hart ME, et al. 3-Iodothyronamine is an endogenous and rapidacting derivative of thyroid hormone. Nat Med. 2004;10:638-642.
27. Jones CK, Eberle EL, Shaw DB, McKinzie DL, Shannon HE. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats. J Pharmacol Exp Ther. 2005;312:1055-1063.
28. Wolinsky TD, Swanson CJ, Zhong H, Smith KE, Branchek TA, Gerald CP. Deficit in Prepulse Inhibition and Enhanced Sensitivity to Amphetamine in Mice Lacking the Trace Amine-1 Receptor poster. Paper presented at: The American College of Neuropsychopharmacology (ACNP) 43rd Annual Meeting; December 12-16, 2004; San Juan, Puerto Rico.
29. Hirashima A, Pan C, Shinkai K, et al. Quantitative structure-Activity studies of octopaminergic agonists and antagonists against nervous system of Locusta migratoria. Bioorg Med Chem. 1998;6:903-910.
30. Hirashima A, Nagata T, Pan C, Kuwano E, Taniguchi E, Eto M. Three-dimensional molecular field analyses of octopaminergic agonists and antagonists for the locust neuronal octopamine receptor class 3. J Mol Graph Model. 1999;17:198-218.
31. Hirashima A, Morimoto M, Kuwano E, Taniguchi E, Eto M. Three-dimensional common-feature hypotheses for octopamine agonist 2-(arylimino)imidazolidines. Bioorg Med Chem. 2002;10:117-123.